TORONTO--(BUSINESS WIRE)--Northern Biologics Inc., a developer of first-in-class immuno-oncology products, today announced that its lead asset, MSC-1, is being featured at key scientific meetings in ...
The following slide deck was published by MSC Industrial Direct Co., Inc. in conjunction with their 2025 Q2 earnings call.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback